Tarsus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Jennison Associates LLC(5.7%)
Tarsus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(9.9%)
Tarsus Pharmaceuticals | 4:持股变动声明-高管 Lin Elizabeth Yeu
Tarsus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Frazier Life Sciences IX, L.P.(4.2%),FHMLS IX, L.P.(4.2%)等
Tarsus Pharmaceuticals | 8-K:重大事件
Tarsus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.51%)
Tarsus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(9.9%)
Tarsus Pharmaceuticals | 4:持股变动声明-董事 Morrison Scott W
Tarsus Pharmaceuticals | 4:持股变动声明-董事 Morrison Scott W
Tarsus Pharmaceuticals | 4:持股变动声明-董事 LINK WILLIAM J PHD
Tarsus Pharmaceuticals | 144:拟议出售证券
Tarsus Pharmaceuticals | 10-Q:2024财年二季报
Tarsus Pharmaceuticals | 8-K:Tarsus报告了2024年第二季度和年初至今的财务业绩和最近的业务成就
Tarsus Pharmaceuticals | 4:持股变动声明-董事 Crane Rosemary A
Tarsus Pharmaceuticals | 4:持股变动声明-董事 Goldberg Andrew D.
Tarsus Pharmaceuticals | 4:持股变动声明-董事 LINK WILLIAM J PHD
Tarsus Pharmaceuticals | 4:持股变动声明-董事 Lin Elizabeth Yeu
Tarsus Pharmaceuticals | 4:持股变动声明-董事 Morrison Scott W
Tarsus Pharmaceuticals | 4:持股变动声明-董事 CHAUDHURI BHASKAR
Tarsus Pharmaceuticals | 4:持股变动声明-董事 YARNO WENDY L
暂无数据
暂无数据